The US Navy has awarded a follow-on contract to information technology, engineering, and science solutions and services provider Leidos to study the health impact of undersea operations on submariners.
The deal is valued at approximately $28m and has been awarded by the US Naval Medical Logistics Command to support biomedical research and development at its Naval Submarine Medical Research Laboratory (NSMRL).
Leidos Health Group president Jon Scholl said: “Leidos employs a multi-disciplinary approach to research and development (R&D) that has enabled us to uncover meaningful and actionable information to support the customer’s mission.
“Our focus is to provide insight that aids in decision-making, identifies potential health threats and optimises safety within these challenging operational environments.”
Work under the new five-year, indefinite delivery / indefinite quantity (IDIQ) contract will be carried out at the US Navy’s facility in Groton, Connecticut.
The navy’s NSMRL is intended to provide latest human-centric research solutions to sustain the US’s superiority in the undersea domain.
Leidos will be required to carry out the project by conducting research studies and analyses under the agreement, as well as developing guidelines and supporting new initiatives.
The study regarding the impact of undersea operations on submariners’ health will focus on wellness, psychological factors, shipboard and diving force health protection, and various human factors, along with undersea warfighter health and performance considerations.
Leidos is headquartered in Reston, Virginia, and is engaged in the provision of solutions for the defence, intelligence, homeland security, civil and health markets.